A federal lawsuit against OhioHealth alleges the system blocked lower-cost health plans from expanding in its market. The case raises uncomfortable but important questions about how hospitals protect commercial reimbursement and how market dominance shapes employer plan options.

While the legal outcome remains uncertain, the broader signal is clear: provider-side market power is under scrutiny. If enforcement efforts increase, dominant regional systems may face pressure on premium commercial contracting strategies that have historically supported cross-subsidization.

In this analysis, I explore what the OhioHealth case reveals about structural margin tension, affordability, and how revenue cycle leaders should be thinking about contracting assumptions as we move toward 2030.

Legislation aimed at breaking up vertically integrated insurers signals growing scrutiny of concentrated market power in healthcare. For more than a decade, integration across insurance, pharmacy benefit management, provider networks, and data platforms has reshaped negotiation dynamics between payers and hospitals.

Even if structural breakup does not occur immediately, increased regulatory attention changes the operating environment. Market configuration affects contract leverage, denial patterns, data access, and payment predictability.

In this piece, I examine what renewed legislative pressure on vertically integrated payviders could mean for revenue cycle leaders planning toward 2030, and why market structure deserves as much attention as reimbursement rates.

Recent CMS updates and CMMI alignment pledges may look incremental on the surface, but together they signal something broader: cost containment is becoming the operating environment.

When payers align with CMMI access models and CMS emphasizes affordability and marketplace flexibility, the impact does not stop at policy headlines. It flows downstream into contract structure, reporting requirements, patient cost responsibility, and denial patterns.

For revenue cycle leaders, this is not background noise. It is early direction.

In this piece, I examine what the latest CMS and CMMI signals mean for margin pressure, patient balance exposure, and operational complexity between now and 2030.

AI is already embedded in healthcare operations. Oversight hasn’t kept pace.

Recent reporting shows nearly 20 percent of healthcare professionals are using unauthorized AI tools. At the same time, embedded EHR AI and autonomous coding platforms are expanding rapidly inside revenue cycle workflows.

None of this is inherently reckless. But when adoption moves faster than visibility, small shifts in documentation, coding, and denial patterns can go unnoticed.

This isn’t an IT side conversation. It’s a revenue stability issue.

In this piece, I break down what shadow AI, embedded EHR AI, and autonomous coding actually mean for revenue cycle leaders and why governance discipline matters more than speed.

Vertical integration is no longer just a policy debate. It’s a revenue cycle risk. Congressional hearings with payer CEOs exposed how control over prior authorization, denial definitions, and payment timing has shifted upstream. Hospitals can no longer treat RCM as an internal efficiency problem when structural forces outside their control increasingly determine cash flow and patient experience.

AI in healthcare isn’t the disruption people fear. It’s revealing long-standing breakdowns in access, communication, and revenue cycle infrastructure, and forcing leaders to redesign for what comes next.

The Kaufman Hall 2025 Performance Outlook confirms a shift from growth to resilience. Here’s what rising costs, denials, access breakdowns, and workforce strain mean for RCM 2030.

A new proposed rule would strengthen insurer price transparency requirements. Here is what is actually new, what is not, and why it matters for hospitals and CFOs.

Hospital adoption of AI in revenue cycle management is accelerating rapidly, but technology is not the limiting factor. Operational readiness is. New survey data shows AI is gaining traction in documentation, coding, and mid-cycle workflows, yet cost pressure, staffing constraints, and integration complexity are slowing progress. This post explains why operations, not AI skepticism, are now the real bottleneck.

New analysis from Premier estimates that Public Law 119-21 will reduce U.S. hospital revenue by $68.6 billion across 2026 and 2027, driven by coverage losses and rising uncompensated care. This is not a short-term adjustment but a structural shift in payer mix and margin protection. This post breaks down where the losses concentrate and what CFOs should do now to mitigate risk.

New Gallup data shows Americans now view healthcare cost as the country’s most urgent health problem, with trust in the system at a historic low. This post explains why the crisis isn’t about medicine, but about the financial experience, and why I wrote Hospital Bill Survival Guide and Humanizing Revenue Cycle Management to address the trust gap that billing systems continue to create.

CMS’s proposal of 24 new quality and efficiency measures is not a routine update. It is a quiet signal of the future operating model for hospitals. Digital data submission, real-time coordination, and measurable patient engagement are no longer optional. This analysis explains why these measures matter to revenue cycle leaders and how they reinforce the shift toward a fully integrated, digital-first financial ecosystem.

Oracle’s Q2 FY26 earnings call was framed as a cloud and AI infrastructure story, not a healthcare one. But buried inside it were signals hospital and revenue cycle leaders should not ignore.

This is not about Oracle stock or AI hype. It is about what large platform companies are trying to become. By 2030, the winners in healthcare technology will not be the loudest AI brands. They will be the ones that embed AI into workflow, unify data across systems, and reduce the cost of running the business.

Oracle made it clear it is chasing that future. Healthcare should pay attention.

A Fierce Healthcare article shows how payers are treating AI, interoperability, and vendor governance as core infrastructure rather than experimentation. This analysis explains what that shift means for hospitals and why it validates key predictions outlined in RCM 2030 about consolidation, transparency, and AI maturity.

Fitch’s 2026 outlook confirms that nonprofit hospital margins are stabilizing, but at a permanently lower level. Structural pressures tied to payer mix, labor, and Public Law 119-21 are reshaping what financial sustainability looks like. This analysis explains why hospitals must stop planning for a return to “normal” and start designing a new operating reality for 2026 and beyond.

Congress has extended Medicare’s Hospital at Home waivers through 2030, signaling that acute inpatient care is no longer tied to a building. For revenue cycle leaders, this shift has major implications for billing accuracy, automation, quality reporting, and financial operations that must now function beyond hospital walls. This analysis breaks down what Hospital at Home means for RCM readiness through 2030.

The Cerner breach is not just a cybersecurity failure. It is a revenue cycle warning. Legacy systems, delayed disclosure, and vendor dependency expose hospitals to cash flow disruption, billing disputes, and operational paralysis. This analysis explains why cybersecurity must be embedded into revenue cycle planning as a core continuity strategy heading toward 2030.

MedPAC’s 2027 draft recommendations may look routine on the surface, but they send a clear signal to revenue cycle leaders planning for 2030. With Medicare margins still deeply negative and safety-net funding becoming more targeted, hospitals will not be able to rely on broad payment increases. This analysis explains what the update means for cost discipline, automation, safety-net exposure, and long-term RCM readiness.

Hospital CFO turnover is accelerating, and the risk is no longer theoretical. As the CFO role expands to include revenue cycle oversight, cybersecurity, automation, and policy risk, leadership gaps now threaten margin stability. This analysis breaks down why CFO succession planning has become a financial imperative and what boards and CEOs must do now to protect continuity through 2030.

CMS’s new ACCESS Model is not just a chronic-care pilot. It signals a structural shift toward outcome-based, digitally managed reimbursement. For revenue cycle leaders, ACCESS previews how recurring payments, documentation standards, and data quality expectations will reshape chronic-care economics by 2030.